Icon
+91 94997 68112
Login Register

Savaysa - (15, 30, 60 mg; Tablet, Oral)

Edoxaban Daiichi Sankyo
15, 30, 60 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
None None
SAVAYSA (edoxaban) is a prescription medicine used to reduce the risk of stroke and blood clots in people who have atrial fibrillation not caused by a heart valve problem
Yes
**** ** *****. *** **** ********* ****** '*** *** *** ** ****** ** ****, *** *** **** *** ***** ******** ** *** ****. ** ** ******** **** ***** ***** * **** *** ** '*** *** * **** ** ** '***, ***** ** *** ** *** *** *********.
Savaysa Patent 1 Patent 2
***** ****** *** ********* **** ***
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** ****** *** \ ********* -**- *** ********* ********* ******** ***** *** ****
  1. *** **, **** : * **** ** ***** ** ******* *******.
  2. *** **, **** : ***** ******** ********* ******** **** *** *** ******** ******. ** ****** **** ***** * **** *** *** ***** **** *** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.